Locations:
SearchAdvertisement
Experts weigh in on key advancements from the past year
Perspectives from leading Cleveland Clinic co-investigators
Other factors explain diabetic patients’ poorer outcomes after bypass
Glycemic control, weight loss endure out to five years
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
No clinical advantage to either rhythm or rate control
Also finds PCSK9 inhibitor more potent than ezetimibe in statin-intolerant patients
Trial stopped early after evacetrapib fails to budge event rate
Risk factors surge as patients grow younger, more obese
Seven high-profile studies ranging from TAVR to lipid-lowering
Endovascular procedures associated with lower mortality, LOS, cost vs. surgical bypass
Advertisement
Advertisement